Literature DB >> 24322275

Specific MAIT cell behaviour among innate-like T lymphocytes in critically ill patients with severe infections.

David Grimaldi1,2,3,4,5, Lionel Le Bourhis6,7,8, Bertrand Sauneuf9, Agnès Dechartres10,11, Christophe Rousseau12,13,10, Fatah Ouaaz12,13,10, Maud Milder6,7,8, Delphine Louis6,7,8, Jean-Daniel Chiche9,12,13,10, Jean-Paul Mira9,12,13,10, Olivier Lantz6,7,8, Frédéric Pène14,15,16,17.   

Abstract

PURPOSE: In between innate and adaptive immunity, the recently identified innate-like mucosal-associated invariant T (MAIT) lymphocytes display specific reactivity to non-streptococcal bacteria. Whether they are involved in bacterial sepsis has not been investigated. We aimed to assess the number and the time course of circulating innate-like T lymphocytes (MAIT, NKT and γδ T cells) in critically ill septic and non-septic patients and to establish correlations with the further development of intensive care unit (ICU)-acquired infections.
METHODS: We prospectively enrolled consecutive patients with severe sepsis and septic shock. Controls were critically ill patients with non-septic shock and age-matched healthy subjects. Circulating innate-like lymphocytes were enumerated using a flow cytometry assay at day 1, 4 and 7.
RESULTS: One hundred and fifty six patients (113 severe bacterial infections, 36 non-infected patients and 7 patients with severe viral infections) and 26 healthy subjects were enrolled into the study. Patients with severe bacterial infections displayed an early decrease in MAIT cell count [median 1.3/mm(3); interquartile range (0.4-3.2)] as compared to control healthy subjects [31.1/mm(3) (12.1-45.2)], but also to non-infected critically ill patients [4.3/mm(3) (1.4-13.2)] (P < 0.0001 for all comparisons). In contrast NKT and γδ T cell counts did not differ between patients groups. The multivariate analysis identified non-streptococcal bacterial infection as an independent determinant of decrease in MAIT cell count. Furthermore, the incidence of ICU-acquired infections was higher in patients with persistent MAIT cell depletion.
CONCLUSIONS: This large human study provides valuable information about MAIT cells in severe bacterial infections. The persistent depletion of MAIT cells is associated with the further development of ICU-acquired infections.

Entities:  

Mesh:

Year:  2013        PMID: 24322275     DOI: 10.1007/s00134-013-3163-x

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  31 in total

Review 1.  Guidelines for the management of intravascular catheter-related infections.

Authors:  L A Mermel; B M Farr; R J Sherertz; I I Raad; N O'Grady; J S Harris; D E Craven
Journal:  Clin Infect Dis       Date:  2001-04-03       Impact factor: 9.079

Review 2.  Autoreactivity by design: innate B and T lymphocytes.

Authors:  A Bendelac; M Bonneville; J F Kearney
Journal:  Nat Rev Immunol       Date:  2001-12       Impact factor: 53.106

Review 3.  CD1d- and MR1-restricted invariant T cells: of mice and men.

Authors:  Emmanuel Treiner; Olivier Lantz
Journal:  Curr Opin Immunol       Date:  2006-07-25       Impact factor: 7.486

4.  Invariant V(alpha)19i T cells regulate autoimmune inflammation.

Authors:  J Ludovic Croxford; Sachiko Miyake; Yi-Ying Huang; Michio Shimamura; Takashi Yamamura
Journal:  Nat Immunol       Date:  2006-07-30       Impact factor: 25.606

Review 5.  Human Vgamma9Vdelta2 T cells: promising new leads for immunotherapy of infections and tumors.

Authors:  Marc Bonneville; Emmanuel Scotet
Journal:  Curr Opin Immunol       Date:  2006-07-25       Impact factor: 7.486

6.  Antimicrobial activity of mucosal-associated invariant T cells.

Authors:  Lionel Le Bourhis; Emmanuel Martin; Isabelle Péguillet; Amélie Guihot; Nathalie Froux; Maxime Coré; Eva Lévy; Mathilde Dusseaux; Vanina Meyssonnier; Virginie Premel; Charlotte Ngo; Béatrice Riteau; Livine Duban; Delphine Robert; Shouxiong Huang; Martin Rottman; Claire Soudais; Olivier Lantz
Journal:  Nat Immunol       Date:  2010-06-27       Impact factor: 25.606

Review 7.  Mucosal-associated invariant T cells: unconventional development and function.

Authors:  Lionel Le Bourhis; Lucia Guerri; Mathilde Dusseaux; Emmanuel Martin; Claire Soudais; Olivier Lantz
Journal:  Trends Immunol       Date:  2011-04-02       Impact factor: 16.687

8.  MR1-restricted V alpha 19i mucosal-associated invariant T cells are innate T cells in the gut lamina propria that provide a rapid and diverse cytokine response.

Authors:  Izumi Kawachi; Jorge Maldonado; Carey Strader; Susan Gilfillan
Journal:  J Immunol       Date:  2006-02-01       Impact factor: 5.422

Review 9.  2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference.

Authors:  Mitchell M Levy; Mitchell P Fink; John C Marshall; Edward Abraham; Derek Angus; Deborah Cook; Jonathan Cohen; Steven M Opal; Jean-Louis Vincent; Graham Ramsay
Journal:  Intensive Care Med       Date:  2003-03-28       Impact factor: 17.440

10.  Human MAIT cells are xenobiotic-resistant, tissue-targeted, CD161hi IL-17-secreting T cells.

Authors:  Mathilde Dusseaux; Emmanuel Martin; Nacer Serriari; Isabelle Péguillet; Virginie Premel; Delphine Louis; Maud Milder; Lionel Le Bourhis; Claire Soudais; Emmanuel Treiner; Olivier Lantz
Journal:  Blood       Date:  2010-11-17       Impact factor: 22.113

View more
  85 in total

Review 1.  MAIT, MR1, microbes and riboflavin: a paradigm for the co-evolution of invariant TCRs and restricting MHCI-like molecules?

Authors:  Stanislas Mondot; Pierre Boudinot; Olivier Lantz
Journal:  Immunogenetics       Date:  2016-07-08       Impact factor: 2.846

2.  Multiple layers of heterogeneity and subset diversity in human MAIT cell responses to distinct microorganisms and to innate cytokines.

Authors:  Joana Dias; Edwin Leeansyah; Johan K Sandberg
Journal:  Proc Natl Acad Sci U S A       Date:  2017-06-19       Impact factor: 11.205

Review 3.  The role of mucosal-associated invariant T cells in infectious diseases.

Authors:  Emily B Wong; Thumbi Ndung'u; Victoria O Kasprowicz
Journal:  Immunology       Date:  2016-10-26       Impact factor: 7.397

4.  On the verge of using an immune toolbox in the intensive care unit?

Authors:  Frédéric Pène; Jean-Louis Vincent; Ignacio Martin-Loeches
Journal:  Intensive Care Med       Date:  2017-05-11       Impact factor: 17.440

Review 5.  MAIT cells and pathogen defense.

Authors:  Siobhán C Cowley
Journal:  Cell Mol Life Sci       Date:  2014-08-28       Impact factor: 9.261

6.  The editorial policy of Intensive Care Medicine.

Authors:  Élie Azoulay
Journal:  Intensive Care Med       Date:  2016-08-04       Impact factor: 17.440

7.  Mucosal-associated invariant T cell alterations in obese and type 2 diabetic patients.

Authors:  Isabelle Magalhaes; Karine Pingris; Christine Poitou; Stéphanie Bessoles; Nicolas Venteclef; Badr Kiaf; Lucie Beaudoin; Jennifer Da Silva; Omran Allatif; Jamie Rossjohn; Lars Kjer-Nielsen; James McCluskey; Séverine Ledoux; Laurent Genser; Adriana Torcivia; Claire Soudais; Olivier Lantz; Christian Boitard; Judith Aron-Wisnewsky; Etienne Larger; Karine Clément; Agnès Lehuen
Journal:  J Clin Invest       Date:  2015-03-09       Impact factor: 14.808

Review 8.  Sepsis-Induced T Cell Immunoparalysis: The Ins and Outs of Impaired T Cell Immunity.

Authors:  Isaac J Jensen; Frances V Sjaastad; Thomas S Griffith; Vladimir P Badovinac
Journal:  J Immunol       Date:  2018-03-01       Impact factor: 5.422

Review 9.  MR1-dependent antigen presentation.

Authors:  Elham Karamooz; Melanie J Harriff; David M Lewinsohn
Journal:  Semin Cell Dev Biol       Date:  2018-12       Impact factor: 7.727

10.  The Toll-like receptor 9 signalling pathway regulates MR1-mediated bacterial antigen presentation in B cells.

Authors:  Jianyun Liu; Randy R Brutkiewicz
Journal:  Immunology       Date:  2017-06-29       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.